() () said it has completed a fundraising that it says will allow it to complete a follow-on investment in Pluto Digital Assets as well as pursue strategic opportunities in crypto mining, capital investment, decentralised finance (DeFi) and Web 3.0 initiatives, and general working capital purposes.
() revealed encouraging news from Labrador Iron Mines Holdings (LIMH), in which it holds a 12% stake, with LIMH releasing details of a preliminary economic assessment (PEA) of its 52%-owned Houston Project in Canada.
() said Australia’s Therapeutics Goods Administration has approved its drug Feraccru to treat iron deficiency with or without anaemia in adults.
Diagnostics specialist genedrive plc () said it has inked a deal with a US military contracting specialist that will distribute its BioPlex range, which provide rapid tests for threats from pathogens.
() said its Venn Life Sciences business has won a contract to support a phase I clinical study.
() has been awarded a contract worth a minimum of US$960,000 by a customer that wants to use Kromek’s technology in a new radiation technology product.
(), the biotech backer, saw a sharp increase in its net asset value (NAV) per share in 2020. The company’s NAV stood at £328mln at the end of December, up from £202mln a year earlier. The company also announced it has founded a new 49%-owned portfolio company, Twelve Bio, that is a spin-out from the Foundation Centre for Protein Research at the University of…
